CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Bazemore Robert B Director | Purchase · Warrants to purchase ADRs | +30,932 | 30,932 | ||
| 2025-12-16 | Bazemore Robert B Director | Purchase · Pre-Funded Warrants to purchase ADRs | +30,932 | $0.40 | $12K | 30,932 |
| 2025-11-01 | Farag Kameel D. Interim CFO | Grant or award | +32,000 | $0.75 | $24K | 32,000 |
| 2025-11-01 | Farag Kameel D. Interim CFO | Grant or award | +26,619 | $0.75 | $20K | 26,619 |
| 2025-10-22 | Farag Kameel D. Interim CFO | Grant or award | +6,277 | $0.74 | $5K | 6,277 |
| 2025-08-25 | Gaslightwala Abizer CEO | Purchase | +3,000 | $0.90 | $3K | 298,574 |
| 2025-08-22 | Gaslightwala Abizer CEO | Purchase | +8,000 | $0.93 | $7K | 295,574 |
| 2025-08-21 | Gaslightwala Abizer CEO | Purchase | +10,000 | $0.94 | $9K | 287,574 |
| 2025-06-24 | Gaslightwala Abizer President & CEO | Purchase | +5,203 | $1.16 | $6K | 277,574 |
| 2025-06-23 | Gaslightwala Abizer President & CEO | Purchase | +943 | $1.15 | $1K | 272,371 |
| 2025-06-20 | Gaslightwala Abizer President & CEO | Purchase | +10,000 | $1.20 | $12K | 271,428 |
| 2025-06-17 | Gaslightwala Abizer President & CEO | Purchase | +15,000 | $1.20 | $18K | 261,428 |
| 2025-06-13 | Gaslightwala Abizer CEO | Grant or award | +25,000 | $1.19 | $30K | 246,428 |
| 2025-06-12 | Gaslightwala Abizer CEO | Grant or award | +20,000 | $1.23 | $25K | 221,428 |
| 2025-06-10 | Gaslightwala Abizer CEO | Grant or award | +20,000 | $1.27 | $25K | 201,428 |
| 2025-03-20 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2025-03-20 | Neal James R Director | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2025-03-20 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2025-03-20 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2025-03-20 | Patel Samir Rashmikant Director | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 |
Page 5 of 11 · 216 trades